Buy Curosurf 80 mg/mL poractant alfa

Curosurf 80 mg/mL is a suspension containing poractant alfa, used for respiratory support in premature infants. This medication is administered via endotracheal route and is manufactured by Chiesi USA, Inc.

Strength

80 mg/mL

Pack Size

1.5 mL in 1 VIAL, GLASS (10122-510-01)

Manufacturer / TM Owner

Chiesi USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Curosurf 80 mg/mL is primarily used to treat respiratory distress syndrome (RDS) in premature infants. This condition often occurs due to a lack of surfactant in the lungs, which is crucial for proper lung function. The medication helps to improve breathing and reduce the need for mechanical ventilation. What is Curosurf used for? It is specifically designed to provide respiratory support in neonatal intensive care units.

Side Effects

Common effects of Curosurf 80 mg/mL may include improved lung function and reduced respiratory distress in premature infants. Some infants may experience temporary side effects such as changes in oxygen levels or mild respiratory symptoms. These effects are generally monitored closely by healthcare professionals.

Precautions & Warnings

Curosurf 80 mg/mL should be handled with care and administered by trained healthcare professionals. It is important to follow proper storage and handling guidelines to maintain the integrity of the medication. Always consult a healthcare provider for specific precautions and contraindications.

Avoid Interactions

Curosurf 80 mg/mL may interact with other medications or treatments. It is important to inform healthcare providers about all current medications and treatments before administration. Specific interactions should be discussed with a healthcare professional to ensure safe and effective use.

References

Frequently Asked Questions

Curosurf 80 mg/mL is used to treat respiratory distress syndrome (RDS) in premature infants by providing essential surfactant to the lungs.

Curosurf 80 mg/mL is administered via the endotracheal route, directly into the lungs of premature infants under medical supervision.

Common effects include improved lung function and reduced respiratory distress, with some infants experiencing temporary side effects like changes in oxygen levels.

Curosurf 80 mg/mL is manufactured by Chiesi USA, Inc., a reputable pharmaceutical company based in the USA.

Curosurf 80 mg/mL should be handled and administered by trained healthcare professionals, following proper storage and handling guidelines.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.